[go: up one dir, main page]

PT3008172T - Composições de meio de cultura para maturar cardiomicóticos derivados de células estaminais pluripotentes de mamíferos - Google Patents

Composições de meio de cultura para maturar cardiomicóticos derivados de células estaminais pluripotentes de mamíferos

Info

Publication number
PT3008172T
PT3008172T PT147324461T PT14732446T PT3008172T PT 3008172 T PT3008172 T PT 3008172T PT 147324461 T PT147324461 T PT 147324461T PT 14732446 T PT14732446 T PT 14732446T PT 3008172 T PT3008172 T PT 3008172T
Authority
PT
Portugal
Prior art keywords
maturating
culture medium
stem cells
mammalian stem
medium compositions
Prior art date
Application number
PT147324461T
Other languages
English (en)
Original Assignee
Pluriomics B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pluriomics B V filed Critical Pluriomics B V
Publication of PT3008172T publication Critical patent/PT3008172T/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0652Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0657Cardiomyocytes; Heart cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/05Inorganic components
    • C12N2500/10Metals; Metal chelators
    • C12N2500/20Transition metals
    • C12N2500/24Iron; Fe chelators; Transferrin
    • C12N2500/25Insulin-transferrin; Insulin-transferrin-selenium
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/32Amino acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/32Amino acids
    • C12N2500/33Amino acids other than alpha-amino carboxylic acids, e.g. beta-amino acids, taurine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/34Sugars
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/36Lipids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/30Organic components
    • C12N2500/38Vitamins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/90Serum-free medium, which may still contain naturally-sourced components
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30Hormones
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30Hormones
    • C12N2501/33Insulin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30Hormones
    • C12N2501/38Hormones with nuclear receptors
    • C12N2501/395Thyroid hormones
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40Regulators of development
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/998Proteins not provided for elsewhere
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/02Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/45Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT147324461T 2013-06-11 2014-06-06 Composições de meio de cultura para maturar cardiomicóticos derivados de células estaminais pluripotentes de mamíferos PT3008172T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL2010953 2013-06-11

Publications (1)

Publication Number Publication Date
PT3008172T true PT3008172T (pt) 2020-07-21

Family

ID=50981826

Family Applications (1)

Application Number Title Priority Date Filing Date
PT147324461T PT3008172T (pt) 2013-06-11 2014-06-06 Composições de meio de cultura para maturar cardiomicóticos derivados de células estaminais pluripotentes de mamíferos

Country Status (11)

Country Link
US (3) US10696947B2 (pt)
EP (2) EP3708655A1 (pt)
JP (4) JP6682429B2 (pt)
CN (1) CN105473708A (pt)
CA (2) CA3135208A1 (pt)
DK (1) DK3008172T3 (pt)
ES (1) ES2806698T3 (pt)
HU (1) HUE049916T2 (pt)
PL (1) PL3008172T3 (pt)
PT (1) PT3008172T (pt)
WO (1) WO2014200339A1 (pt)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT3008172T (pt) 2013-06-11 2020-07-21 Pluriomics B V Composições de meio de cultura para maturar cardiomicóticos derivados de células estaminais pluripotentes de mamíferos
EP3152300A1 (en) * 2014-06-06 2017-04-12 Pluriomics B.v. Cardiomyocyte maturation
WO2016055519A1 (en) 2014-10-07 2016-04-14 Max-Delbrück-Centrum für Molekulare Medizin Endogenous retrovirus transcription as a marker for primate naïve pluripotent stem cells
US10613078B2 (en) 2015-02-20 2020-04-07 Ncardia B.V. Assays for measuring cardiotoxicity
PL3344758T3 (pl) 2015-09-01 2022-01-03 Ncardia B.V. Sposób in vitro różnicowania populacji ludzkich pluripotentnych komórek macierzystych w populację komórek kardiomiocytów
CN105567635A (zh) * 2016-02-21 2016-05-11 中国医科大学附属第一医院 一种改良的Neurobasal B27培养基、制备方法及应用
KR102634265B1 (ko) * 2016-08-26 2024-02-08 더 유니버서티 어브 퀸슬랜드 심근세포 성숙
CN106754663A (zh) * 2016-11-30 2017-05-31 中国人民解放军第三军医大学第三附属医院 促进成年哺乳动物心肌细胞存活的体外培养方法及监测成年哺乳动物心肌细胞增殖的方法
CN106957815B (zh) 2017-03-16 2021-05-07 杨涛 一种用于人类多潜能干细胞的无血清培养基的配方
NL2019618B1 (en) 2017-09-22 2019-03-28 Ncardia B V In vitro method for providing stem cell derived cardiomyocytes
CN111565731B (zh) 2017-10-24 2024-03-08 达莉亚·伊兰妮 治疗缺血性疾病的方法
CN108456654A (zh) * 2018-02-22 2018-08-28 上海产业技术研究院 用于促进干细胞来源心肌细胞成熟的无血清培养体系
AU2019241702B2 (en) * 2018-03-30 2023-07-27 Orizuru Therapeutics, Inc Heterocyclic compound
US12018281B2 (en) 2018-03-30 2024-06-25 Kyoto University Cardiomyocyte maturation promoter
WO2020247957A2 (en) * 2019-06-06 2020-12-10 President And Fellows Of Harvard College Cardiomyocytes and compositions and methods for producing the same
CN111454886A (zh) * 2020-05-12 2020-07-28 广东源心再生医学有限公司 一种增强型心肌细胞培养液及其应用
CN112708591B (zh) * 2020-12-24 2022-04-29 南京周子未来食品科技有限公司 一种用于肌肉干细胞体外分化的化学成分明确的培养基
CN113073076B (zh) * 2021-04-24 2022-09-09 华中科技大学同济医学院附属协和医院 一种将多能干细胞分化为瓣膜内皮细胞与瓣膜间质细胞的分化方法
CN113215085B (zh) * 2021-05-07 2024-05-10 澳门大学 一种脂类物质添加剂及其应用
US20250019658A1 (en) * 2021-11-17 2025-01-16 The Governing Council Of The University Of Toronto Maturation medium for pluripotent stem cell-derived cardiomyocytes
EP4447983A1 (en) * 2021-12-14 2024-10-23 Reverse Bioengineering, Inc. Improved methods for inducing the maturation of mammalian cells
JP7798302B2 (ja) * 2022-01-11 2026-01-14 三井化学株式会社 薬剤の、心筋細胞に対する作用を評価する方法
WO2024004960A1 (ja) * 2022-06-27 2024-01-04 武田薬品工業株式会社 細胞の培養方法
JPWO2024010020A1 (pt) 2022-07-08 2024-01-11
EP4558611A4 (en) * 2022-07-22 2025-08-06 Univ Michigan State MATURATION MEDIUM COMPOSITIONS AND METHODS FOR MATURING HUMAN CARDIAC ORGANOIDS
WO2025024725A1 (en) * 2023-07-25 2025-01-30 University Of Washington Electrophysiological maturation of human stem cell derived cardiomyocytes
WO2025254117A1 (ja) * 2024-06-03 2025-12-11 国立大学法人京都大学 成熟心筋細胞の製造法

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3871206D1 (de) 1987-03-24 1992-06-25 Grace W R & Co Basisnaehrmedium fuer eine zellkultur.
WO1990003430A1 (en) 1988-09-23 1990-04-05 Cetus Corporation Cell culture medium for enhanced cell growth, culture longevity and product expression
JPH03180176A (ja) * 1989-11-16 1991-08-06 W R Grace & Co 細胞培養のための基礎栄養培地
US6221911B1 (en) * 1995-06-07 2001-04-24 Karo Bio Ab Uses for thyroid hormone compounds or thyroid hormone-like compounds
GB2393734B (en) * 2001-07-12 2005-07-27 Geron Corp Cells of the cardiomyocyte lineage produced from human pluripotent stem cells
CA2473360A1 (en) * 2002-01-25 2003-08-07 Genzyme Corporation Serum-free media for chondrocytes and methods of use thereof
WO2004098490A2 (en) 2002-05-17 2004-11-18 Mount Sinai School Of Medicine Of New York University Mesoderm and definitive endoderm cell populations
CA2391118A1 (en) 2002-06-21 2003-12-21 Universite Du Quebec A Montreal Oxytocin as cardiomyogenesis inducer and uses thereof
US9101590B2 (en) 2005-07-29 2015-08-11 Yale University Defined culture conditions of human embryonic stem cells
JP2007124982A (ja) 2005-11-07 2007-05-24 Toray Ind Inc 細胞培養液および細胞培養方法
JP2007228815A (ja) 2006-02-27 2007-09-13 Gifu Univ 胚性幹細胞の維持方法
GB0622395D0 (en) 2006-11-09 2006-12-20 Univ Cambridge Tech Methods relating to pluripotent cells
GB0622394D0 (en) 2006-11-09 2006-12-20 Univ Cambridge Tech Differentiation of pluripotent cells
CN100540659C (zh) 2006-12-22 2009-09-16 北京维通达生物技术有限公司 一种培养小鼠胚胎干细胞的方法及其专用培养基
US9062122B2 (en) 2007-01-19 2015-06-23 Mount Sinai School Of Medicine Of New York University Targeting the Rosa26 gene in human embryonic stem cells
WO2008094597A2 (en) * 2007-01-30 2008-08-07 University Of Georgia Research Foundation, Inc. Early mesoderm cells, a stable population of mesendoderm cells that has utility for generation of endoderm and mesoderm lineages and multipotent migratory cells (mmc)
WO2008112323A1 (en) * 2007-03-15 2008-09-18 California Stem Cell, Inc. Cardiomyocytes and methods of producing and purifying cardiomyocytes
WO2010007031A2 (en) * 2008-07-14 2010-01-21 Novartis Ag Methods for improving cardiac differentiation of human embryonic stem cells
US10894944B2 (en) 2009-04-10 2021-01-19 Monash University Cell culture media
EP2488631B1 (en) * 2009-10-13 2020-01-08 Stemcell Technologies Inc. Manipulation of osmolality for differentiating stem cells
EP4166652A1 (en) * 2009-11-12 2023-04-19 Technion Research & Development Foundation Ltd. Culture media, cell cultures and methods of culturing pluripotent stem cells in an undifferentiated state
WO2011100286A2 (en) * 2010-02-09 2011-08-18 The Johns Hopkins University Compositions and methods of generating a differentiated mesodermal cell
EP2624536A1 (en) * 2010-09-29 2013-08-07 Sharp Kabushiki Kaisha Signal processing device, control program, and integrated circuit
US20140178894A1 (en) * 2011-04-20 2014-06-26 Novartis Forschungsstiftung, Zweigniederlassung Culture medium suitable for the culture of undifferentiated cells
DK2737056T3 (en) 2011-07-29 2018-05-22 Cellular Dynamics Int Inc Metabolic maturation in stem cell-derived tissue cells
KR101996343B1 (ko) 2012-01-27 2019-07-05 고쿠리츠 다이가쿠 호진 교토 다이가쿠 전능성 줄기세포의 심근분화 유도방법
CN103365555A (zh) * 2012-03-31 2013-10-23 国际商业机器公司 数据处理方法和系统、数据收集方法和系统
PT3008172T (pt) * 2013-06-11 2020-07-21 Pluriomics B V Composições de meio de cultura para maturar cardiomicóticos derivados de células estaminais pluripotentes de mamíferos

Also Published As

Publication number Publication date
JP6682429B2 (ja) 2020-04-15
HUE049916T2 (hu) 2020-11-30
CN105473708A (zh) 2016-04-06
US12043846B2 (en) 2024-07-23
JP2020022460A (ja) 2020-02-13
EP3708655A1 (en) 2020-09-16
DK3008172T3 (da) 2020-07-20
US20160122718A1 (en) 2016-05-05
WO2014200339A1 (en) 2014-12-18
EP3008172A1 (en) 2016-04-20
JP2022031684A (ja) 2022-02-22
CA2914922A1 (en) 2014-12-18
CA2914922C (en) 2021-11-30
JP2016521571A (ja) 2016-07-25
PL3008172T3 (pl) 2020-09-21
US20200370018A1 (en) 2020-11-26
ES2806698T3 (es) 2021-02-18
US20250066734A1 (en) 2025-02-27
EP3008172B1 (en) 2020-05-06
US10696947B2 (en) 2020-06-30
CA3135208A1 (en) 2014-12-18
JP2024040143A (ja) 2024-03-25

Similar Documents

Publication Publication Date Title
HUE049916T2 (hu) Tenyésztõközeg-készítmények pluripotens emlõs õssejtekbõl származó szívizomsejtek érlelésére
IL290485A (en) Substrate for the culture of stem cells
IL250340A0 (en) Growth media for the culture of pluripotent stem cells
IL234095A0 (en) Growth of mesenchymal stem cells in culture
EP3060650A4 (en) Culturing pluripotent stem cells
PT2893001T (pt) Método para cultura de células estaminais mesenquimatosas
ZA201707452B (en) Cell culture compositions and methods for polypeptide production
SG11201505965TA (en) Culture method for stable undifferentiated proliferation of pluripotent stem cells
SG11201706886PA (en) Cell culture method for mesenchymal stem cells
SG10201811616SA (en) Cell culture media
GB201117469D0 (en) Culture media for pluripotent stem cells
EP3048169A4 (en) Method for preparing pluripotent stem cells
IL227529A0 (en) Compounds and methods of cell transplantation
EP3184627A4 (en) Culture medium for mesenchymal stem cells
EP3064575A4 (en) Method for differentiating pluripotent stem cell induced from mesenchymal stem cell into hepatocyte
EP3124602A4 (en) Culture medium for pluripotent stem cells
EP3041930A4 (en) Method for culturing mesenchymal stem cells according to cell size
EP3202896A4 (en) Method for culturing pluripotent stem cells
SG11201509767UA (en) Medium for culturing stem cells
ZA201504388B (en) Method for culturing pluripotent stem cells
PL3436568T3 (pl) Podłoże hodowlane do pluripotencjalnych komórek macierzystych
SG11201406622UA (en) An in vitro method for culturing stem cells
SG11201703512QA (en) Medium composition for culturing stem cells
ZA201603961B (en) Bioreactor for in vitro plant culture
IL229203A (en) A human substrate for human mesenchymal stem cells